ALEXION BIOPHARMACEUTICAL INDUSTRY

FELLOWSHIP
PROGRAMS
GLOBAL MEDICAL
COMMUNICATIONS–
GLOBAL MEDICAL
AFFAIRS

GLOBAL
PATIENT SAFETY

GLOBAL
REGULATORY AFFAIRS

GLOBAL VALUE,
ACCESS & PRICING

US MEDICAL AFFAIRS

PHARMACEUTICAL
DEVELOPMENT AND
CLINICAL SUPPLY

US REVIEW &
STRATEGY
SERVING
PATIENTS IN 2024
70 COUNTRIES
CONTENTS
04 About Alexion

30+ 08 Fellowship Program Overview

YEARS OF
LEADERSHIP IN 10 Global Medical Communications–
Global Medical Affairs

RARE DISEASE 14 Global Patient Safety

16 Global Regulatory Affairs

6 18 Global Value, Access & Pricing

APPROVED 20 US Medical Affairs

THERAPIES 22 Pharmaceutical Development

and Clinical Supply

24 US Review and Strategy

28 MCPHS
7
RARE
30 Application Requirements

DISEASES

ABOUT ALEXION
 At Alexion, the
ABOUT
commitment to

ALEXION improving the lives

of patients living
with rare diseases
Alexion, AstraZeneca Rare Disease, is the group creates an inspiring
within AstraZeneca focused on rare diseases. and motivational
Our mission is to transform the lives of people atmosphere across
affected by rare diseases through the development the organization.”
and delivery of innovative medicines, as well as CHRISTINA MILLER, PharmD, RPh

supportive technologies and healthcare services.

At Alexion, we invest in and value people who believe in the
importance of our mission and understand what it takes to
ALEXION HEADQUARTERS deliver on it. Our culture is rooted in integrity, inclusiveness, and
Alexion is headquartered
our dedication to joining and supporting the communities in
in Boston, Massachusetts. Each
fellowship program is two years which we live and work.
in duration and most will be
based in Boston.
Today, our internal research efforts focus on leveraging our
30+ years of leadership in rare disease. This knowledge allows WE FOLLOW WE PUT WE PLAY WE DO THE WE ARE
THE SCIENCE PATIENTS FIRST TO WIN RIGHT THING ENTREPRENEURIAL
us to innovate and evolve into new areas where there is great
unmet need and opportunity to help patients and families
fully live their best lives. Our development efforts focus on the
core therapeutic areas of hematology, nephrology, neurology, OUR
metabolics, bone metabolism, cardiology and ophthalmology.

We continue to lead in complement science by exploring

VALUES
new targets, and expand beyond complement to strengthen
our clinical-stage pipeline through internal and external Our culture values are the guiding principles behind
development opportunities in our core areas. why and how we do our important work
Every day, people living with rare diseases, their caregivers, The work we do is guided by people affected by rare diseases.
and families face fears of the unknown with courage, tenacity, We are driven to continuously innovate and create meaningful
and grace; we believe it is our responsibility to listen to, value in all we do to help patients and families fully live their
understand, and change their lives. best lives.
OUR

COMMITMENT TO THERAPEUTIC
INCLUSION & DIVERSITY AREAS
We create a working environment where every employee has a sense of
belonging, regardless of gender, race, ethnicity, religion, age, disability status
or sexual orientation.

This includes equitable

compensation, benefits and Neurology Hematology
opportunities for development
and advancement. Ophthalmology Nephrology
We believe that inclusion is a right
and diversity is a strength. Both
make a fundamental contribution to
the success of our company because
innovation requires breakthrough
ideas that only come from a diverse
workforce empowered to challenge
conventional thinking.

We believe our shared creativity

unlocks challenges and brings new
solutions. Incorporating Inclusion
and Diversity (I&D) across all aspects CHELSEY VICTOR
of our organization is imperative to LIVING WITH NEUROMYELITIS LIVING WITH PAROXYSMAL
OPTICA SPECTRUM DISORDER NOCTURNAL HEMOGLOBINURIA
innovating for patients, continuous
learning, and growing as individuals
and as a company.

Inclusion and diversity is one of the

Metabolics Cardiology
foundations of our People strategy Bone Metabolism
— driving innovation, engagement
and a sense of connection and
belonging. We focus on four areas:

• EMPOWERING inclusive
leadership

• FOSTERING an environment
where we each speak our minds

• BUILDING and sustaining a

diverse leadership and talent
pipeline

• CONTRIBUTING to society, which

includes our commitments to
ARIA
supplier diversity, clinical trial LIVING WITH HYPOPHOSPHATASIA
diversity, and health equity
ALEXION/MCPHS

FELLOWSHIP
PROGRAM
Alexion, in collaboration with MCPHS, is pleased to offer seven unique
postdoctoral fellowship programs to candidates obtaining a Doctor
of Pharmacy. Through this experience, fellows will gain exposure to
the biopharmaceutical industry, enhancing their understanding and
establishing a foundation as an industry professional.

GLOBAL MEDICAL COMMUNICATIONS–

GLOBAL MEDICAL AFFAIRS
2 POSITIONS. BOSTON, MA
Over the past year at
GLOBAL PATIENT SAFETY Alexion, I have been
1 POSITION. BOSTON, MA
fortunate to work with
GLOBAL REGULATORY AFFAIRS talented and driven
1 POSITION. BOSTON, MA
individuals who are
GLOBAL VALUE, ACCESS & PRICING invested in making
1 POSITION. BOSTON, MA
meaningful impacts for
US MEDICAL AFFAIRS people living with rare
2 POSITIONS. BOSTON, MA
diseases everyday.”
PHARMACEUTICAL DEVELOPMENT MORGAN LOH, PharmD

AND CLINICAL SUPPLY

1 POSITION. NEW HAVEN, CT

US REVIEW AND STRATEGY

1 POSITION. BOSTON, MA
GLOBAL MEDICAL COMMUNICATIONS–
GLOBAL MEDICAL AFFAIRS
GLOBAL MEDICAL COMMUNICATIONS–
Dear Prospective Fellow, GLOBAL MEDICAL AFFAIRS FELLOWSHIP TEAM
Thank you for your interest in the Alexion
2-YEAR PROGRAM Fellowship Program in collaboration with DIANE LAWSON, PharmD, RPh
FELLOWSHIP PROGRAM DIRECTOR; GMC-GMA PROGRAM LEAD
Massachusetts College of Pharmacy and Health
MEDICAL INFORMATION MEDICAL REVIEW ELECTIVE Sciences (MCPHS) University. Diane Lawson is the therapeutic
9 MONTHS 9 MONTHS 6 MONTHS area lead for the Neurology Medical
As we pursue our mission of transforming lives Information-Medical Review team,
through the development of innovative therapies partnering with US and Global functions.
for patients with rare diseases in neurology, Diane’s 20-year pharmaceutical
experience has consisted of various
haematology, and other therapeutic areas—the
leadership positions managing medical
Global Medical Affairs team, including Global
publications, medical information, and
Medical Communications, continues to play a R&D programs designed to advance biopharmaceutical careers
This two-year program offers Second year fellows will have opportunities critical role in serving these patients and raising for physicians and pharmacists new to industry. Prior to
to choose an elective rotation. Fellows will be awareness of the challenges of living with a joining Alexion in 2018, Diane received her Bachelor of Science
fellows the opportunity to gain in Pharmacy at the University of Iowa, and her Doctor of
rare disease.
extensive experience within encouraged to identify areas of interest and Pharmacy from the University of Florida.
I wish you the best of luck as you explore the
seize opportunities to engage in impactful,
Global Medical Communications available opportunities and encourage you to SASHA W. GALLAGHER, PharmD
longitudinal projects in various departments.
and Global Medical Affairs in a consider the Alexion Fellowship Programs. GMC-GMA PRECEPTOR

fast-paced and patient-centric Sincerely, Sasha W. Gallagher is the therapeutic

area lead for Metabolics within the Global
biopharmaceutical company Medical Information-Medical Review team
focused on developing and CHRISTOPHE HOTERMANS, MD, PhD at Alexion. Sasha has more than 15 years
of pharmaceutical industry experience in
FOCUSED DEVELOPMENT SENIOR VICE PRESIDENT, HEAD OF GLOBAL MEDICAL AFFAIRS,
delivering life-changing therapies ALEXION, ASTRAZENECA RARE DISEASE roles of increasing responsibility across
clinical research, pharmacovigilance,
for patients with rare diseases. • Communication and • Collaborating
medical information and medical review.
Interpersonal Skills for Solutions
Sasha received her Bachelor’s degree in Neuroscience from the
University of Virginia and her Doctor of Pharmacy degree from
• Medical and • Project Management
Virginia Commonwealth University.
Scientific Expertise and Prioritization

• Strategic Thinking • Driving for Results AHSAN JAMIL, PharmD

GMC-GMA PRECEPTOR

Global Medical Communications Ahsan Jamil is the therapeutic area lead

continues to play a critical role in for Hematology & Nephrology within
the Global Medical Information-Medical
raising awareness of the challenges Review team. Ahsan has experience
of living with a rare disease.” across various medical affairs roles and
companies within the pharmaceutical
CHRISTOPHE HOTERMANS industry. Prior to joining Alexion, his
experience spanned several therapeutic
areas including oncology, hematology, cardiovascular,
metabolics, biosimilars, and general medicines. Ahsan received
his Doctor of Pharmacy from Rutgers University.
FELLOWSHIP ROTATION 1 FELLOWSHIP ROTATION 2

GLOBAL MEDICAL GLOBAL MEDICAL

GLOBAL MEDICAL COMMUNICATIONS–GLOBAL MEDICAL AFFAIRS FELLOWSHIP TEAM
INFORMATION REVIEW
• DEVELOP and deliver high-quality, balanced, and • DEVELOP strategic partnerships with stakeholders THO DAO, PharmD NICOLE ALDOVER, PharmD
SECOND-YEAR GMC-GMA FELLOW FIRST-YEAR GMC-GMA FELLOW
timely written or verbal medical and scientific from Medical Affairs, Clinical Development, Regulatory
information in response to requests from health care Affairs, Legal, Marketing, Compliance, and others to Alexion’s efforts to prioritize patient The people at Alexion are truly
support the development and approval of robust, needs through innovative therapies what make this fellowship special. I have
professionals and consumers
to serve the rare disease community received an endless amount of support,
compelling, and accurate materials for healthcare
• CONTRIBUTE to the development and maintenance is what drew me to the company. As a encouragement, and guidance since
providers, patients, and other groups
of medical information written responses to second-year fellow in the Global Medical day one. Alexion has built a team who
address a vast array of inquiries to aid HCPs in • PROVIDE comprehensive medical review and Communications-Global Medical Affairs is passionate about the growth of each
fellowship program, I have had the individual fellow and dedicated to our
clinical decision-making consultative expertise for product launch campaigns,
opportunity to make impactful contributions to the Medical successes. I am confident that the cross-functional, rotational
congress symposia, speaker decks, and other
• SUPPORT Medical Information booth activities prior Review and Medical Information teams. I continuously feel experiences and mentorship that the GMC-GMA program
materials used by field Medical Affairs and supported throughout my professional development thanks to provides will only lead to furthering our personal goals and
to, during, and after professional scientific meetings
Commercial colleagues the relationships I have fostered with my preceptors, mentors, professional development. While witnessing their dedication
and medical congresses
and cross-functional partners. I look forward to continuing my in action, I am looking forward to being part of a team that
• COLLABORATE with subject matter experts
• PARTNER with cross-functional teams (e.g., Medical development within the pharmaceutical industry at Alexion!” collaborates to transform patients lives daily.”
across Medical Affairs and Clinical Development to
Affairs, Marketing, Clinical Development, Competitive
ensure the content of promotional and medical CHRISTINA MILLER, PharmD, RPh ZAHRA ARSALAN, PharmD
Intelligence, Pharmacovigilance, Biostatistics, Medical
materials is scientifically appropriate, clinically SECOND-YEAR GMC-GMA FELLOW FIRST-YEAR GMC-GMA FELLOW
Training, Corporate Communications) to contribute to
relevant, and aligned to company strategy
product launch activities, development of competitive At Alexion, the commitment to It is a privilege to be working with
readiness resources, and creation of medical • PARTICIPATE in live meetings of Promotional and improving the lives of patients living a team that focuses on improving the
with rare diseases creates an inspiring quality of life for patients with rare
information deliverables aligning with medical Medical Review Committees, which are comprised
and motivational atmosphere across diseases. I am excited to begin making
strategic initiative of a collaborative, cross-functional team including
the organization. The Global Medical a meaningful impact, guided by the
Medical, Legal, and Regulatory review colleagues Communications-Global Medical Affairs knowledgeable and supportive team
and Commercial or Medical content creators Fellowship offers outstanding experiences here at Alexion. I am grateful for the
ELECTIVE ROTATION DESCRIPTION in both medical information and medical review, in which I rotational opportunities this fellowship offers and look forward
have had opportunities to develop subject matter expertise in to the invaluable mentorship from industry professionals,
Fellows will have the opportunity to choose an the therapeutic area and collaborate with a variety of cross- which will be foundational to a fulfilling career in the
elective rotation. Rotational areas may include: functional partners. The team members are exceptionally pharmaceutical industry.”
supportive of my professional development, and I am confident
• Medical • Health Economics that their mentorship in addition to my accomplishments SATYAHARSHINI REDDY, PharmD
Science Liaison Outcomes Research will be valuable as I continue to advance my career in the FIRST-YEAR GMC-GMA FELLOW

• US Medical Affairs • Global Patient Safety pharmaceutical industry.”

Within my first few interactions
• Regulatory Affairs • Scientific with the Alexion team I immediately
JULIA SETTLER, PharmD, MBA
Communications recognized that this was a program
• Clinical Development SECOND-YEAR GMC-GMA FELLOW
where collaboration and innovation
• Medical Training
Alexion’s devotion to improving the are at the forefront of every action. This
lives of patients living with rare diseases dynamic environment promises not only
is fundamental to the fulfilling nature of professional growth but also offers a
this fellowship program. My preceptors valuable opportunity to make a meaningful impact in the field
have been eager to share their expertise of rare diseases. I am eager to leverage my skills and learn from
and guidance; as a result, I have had the such a forward-thinking group.”
opportunity to expand my knowledge
in the areas of medical information and medical review.
The collaborative, engaging, and innovative culture within
Alexion has built a team who is passionate this company inspires a program that empowers fellows to
about the growth of each individual fellow maximize their potential within this field. During my first
and dedicated to our successes.” year as an Alexion fellow, I have been consistently impressed
with Alexion’s commitment to excellence and dedication to
N I COL E A L D OVE R , Ph a rmD
improving the lives of patients around the globe.”
 GLOBAL PATIENT SAFETY FELLOWSHIP TEAM
GLOBAL PATIENT SAFETY CYNTHIA CARRILLO-INFANTE, MD, PhD
Each year, Alexion, AstraZeneca Rare Disease, GLOBAL PATIENT SAFETY PROGRAM LEAD

offers a fellowship that is designed to train the next Cynthia Carrillo-Infante is a Physician Scientist
generation of patient safety and pharmacovigilance with over 15 years of industry experience in
2-YEAR PROGRAM professionals. This program aims to prepare fellows
Pharmacovigilance overseeing safety of products
throughout their lifecycle. Her expertise includes
ONBOARDING to contribute to the development of innovative safety of small molecules and monoclonal
~ 6 WEEKS therapies that can transform lives globally. antibodies in a broad range of therapeutic areas
(neurology, immunology, infectious diseases, hematology). Cynthia
I am excited to welcome a new fellow that shares our joined Alexion in 2016 and currently serves as Senior Medical Director
SAFETY SCIENTIST SAFETY SCIENTIST ELECTIVE RETURN TO SAFETY SCIENTIST ROTATION
goal of always putting patients first. This fellowship in Global Patient Safety within the complement therapeutic area.
ROTATION 1: ROTATION 2: ROTATION*: ~8 MONTHS
Prior to joining Alexion, Cynthia worked at Biogen and Vertex
POST-MARKETING CLINICAL DEVELOPMENT ~1-3 MONTHS provides pharmacists with a unique opportunity
DRUG SAFETY DRUG SAFETY Pharmaceuticals where she served as the safety physician lead
to gain experience in patient safety across all for several products in development and on the market. Cynthia
~5 MONTHS ~5 MONTHS
therapeutic areas and lifecycles of Alexion products. received her MD from the Panamerican University in Mexico City,
Fellows will engage with various cross-functional Mexico and her PhD in molecular pathology from the University
*Dependent upon interest and availability, the fellow may elect to rotate through additional areas within Safety or other functional areas of Siena, Italy.
(eg. Regulatory Affairs, Medical Affairs, Global Medical Communications, Epidemiology, HCP and Patient Marketing) teams, including clinical development, medical
affairs, quality, and regulatory affairs, to gain a
ASHLEE HORGAN, PharmD, RPh
comprehensive understanding of the critical role GLOBAL PATIENT SAFETY PROGRAM LEAD

of patient safety. Ashlee Horgan is a Director, Safety Scientist

Global Patient Safety (GPS) provides continuous and proactive assessment, in the Global Patient Safety team at Alexion.
We seek colleagues who share our passion for While actively reviewing the safety profile of
management and communication of patient risks associated with alleviating the suffering of those with rare and multiple clinical development and marketed
Alexion products. The department aims to optimize patient safety while underserved diseases and who are driven to ensure products to ensure that their benefit/risk profiles
remain positive, Ashlee also leads patient
complying with global regulatory requirements, being supported by an agile every patient’s well-being is considered throughout safety process improvements to stay on top of
the entire drug development process. Patient Safety
organization, and exemplifying rigorous process management. evolving global regulations. Prior to joining Alexion, Ashlee worked
in Drug Safety at Takeda Pharmaceuticals, and also spent time
enhances the lives of individuals living with rare
at Sanofi Genzyme where she completed a PharmD fellowship
diseases by thoroughly analyzing, understanding,
program and also worked as a Safety Scientist. Ashlee received her
THE ALEXION GLOBAL PATIENT SAFETY FELLOWSHIP KEY ASPECTS OF THE PROGRAM: and managing the benefit-risk profiles associated Doctor of Pharmacy from Albany College of Pharmacy and Health
WILL GIVE THE FELLOW THE OPPORTUNITY TO: with our life-changing and life-saving therapies. Sciences and her Graduate Certificate in Regulatory Affairs from
• This two-year program in the Global Patient Safety
Massachusetts College of Pharmacy and Health Sciences.
• DEVELOP the ability to think strategically and department at Alexion is designed to equip the
ARSHAD MUJEEBUDDIN, MD
understand the role of Patient Safety in the lifecycle fellow with the proper skillset to progress and have ROSETTA TOLLEY, PharmD, RPh
VICE PRESIDENT OF PATIENT SAFETY SECOND-YEAR GLOBAL PATIENT SAFETY FELLOW
of products a successful career in the pharmaceutical industry ALEXION, ASTRAZENECA RARE DISEASE
The value Alexion places on patients and
• UNDERSTAND the benefit/risk balance of orphan • The program consists of core experiences within
their safety, the collaborative team dynamic,
drugs designed to treat devastating diseases Global Patient Safety and features the opportunity for and the opportunities to grow and excel as
the fellow to complete an elective rotation, within a an upcoming safety scientist made Alexion
• CULTIVATE and utilize knowledge in international
separate functional area, depending on the interest of the perfect choice for me when I was looking
pharmacovigilance regulations and guidelines, to for fellowships. Now over halfway through, I
the fellow
increase process effectiveness have had the opportunity to work in both the
• The program affords the fellow the unique opportunity preclinical and post-marketing spaces, protecting patients through
• PARTICIPATE and engage in cross-functional team all stages of the drug development process. It’s an honor to be of
to work on products that treat ultra-rare disease states
projects involving Commercial, Marketing, Medical service to patients with underserved and rare diseases. I can’t wait
with no other treatment options to see what I’ll do next!”
Affairs and Regulatory Affairs to disseminate Global
Patient Safety messages
BOBBY GJORSESKI, PharmD, RPh
• UTILIZE scientific knowledge and research FIRST-YEAR GLOBAL PATIENT SAFETY FELLOW

skills to support safety surveillance and risk What initially drew me to Alexion’s
It’s an honor to be of service to patients GPS fellowship was the vast opportunities
management decisions
with underserved and rare diseases” for professional development within the
• DEVELOP skills to communicate complex safety pharmaceutical industry, particularly in the
messages cross-functionally and influence ROSETTA TOLLEY, PharmD, RPh rare disease space. Despite my lack of safety
experience, I have been able to seamlessly
decision making
transition from student life to a fellow thanks to
the welcoming environment here at Alexion. I am looking forward
to further expanding my patient safety knowledge to better
support patients impacted by rare diseases.”
 GLOBAL REGULATORY AFFAIRS FELLOWSHIP TEAM
GLOBAL REGULATORY AFFAIRS The Global Regulatory Affairs (GRA) JETHRO EKUTA, DVM, PhD, RAC, FRAPS
GLOBAL REGULATORY AFFAIRS PROGRAM LEAD
fellowship has recruited and retained Pharmacy
Jethro is a Vice President of Global Regulatory
trainees across different regions for more than a Affairs at Alexion. He is an accomplished

2-YEAR PROGRAM decade and this fellowship program is an important

step towards bringing in talented fellows to learn
pharmaceutical executive with over 25 years
of experience. Before he joined industry,
Jethro was a Staff Fellow and Clinical
and acquire experience in the regulatory profession. Pharmacology Reviewer at the US Food and
GLOBAL REGULATORY AFFAIRS OPPORTUNITIES Drug Administration (FDA). Jethro holds the
In RA, we help Alexion shape the drug development
degree of Doctor of Veterinary Medicine (DVM) and received his
• Product •  Chemistry, • Regulatory • Regulatory • Regulatory story, translating our impactful science into Doctor of Philosophy (PhD) in Pharmacology and Toxicology from
Strategy Manufacturing, Labeling Intelligence Operations the University of Mississippi. He is certified in Regulatory Affairs
innovative regulatory strategies to gain approval for
and Controls (CMC) (RAC) and is a Fellow of the Regulatory Affairs Professionals Society
treatments for patients with high unmet medical (FRAPS). He currently serves as President, Board of Directors
need, with the highest quality standards. Regulatory Affairs Professionals Society (RAPS).

We champion diversity and inclusion in our teams, ERICA LEE, RAC

Regulatory Affairs (RA) a function within Alexion’s Development, Regulatory which are so important to foster innovation and
GLOBAL REGULATORY AFFAIRS PRECEPTOR

Erica is a Director in the Global Regulatory

and Safety organization, is responsible for the design and execution of develop new solutions for patients. We work across Affairs, Regulatory Science & Execution group
at Alexion. She is the global regulatory lead
innovative regulatory strategies that drive the advancement and approval of the drug development spectrum, ensuring that
for programs in the Hematology/Nephrology
what we do every day will contribute to developing
their products to serve patients. therapeutic areas. She has more than 15
years of pharmaceutical experience in roles
and bringing life changing therapies and improve
related to assay development and Regulatory
the lives of patients and their families – all by a team
strategy. Prior to Alexion, Erica worked at Shire Pharmaceuticals
Through partnership with external stakeholders, RA FOCUSED OBJECTIVES of just over 200 people spread across 17 countries. and Syntimmune, Inc. leading CMC strategy for rare diseases.
colleagues make a positive contribution to the global YEAR 1 Erica received her Bachelor of Arts in Biology and Chemistry at
regulatory environment and provide ongoing support We are keen on inspiring and being inspired by Clark University.
• ASSIST with the planning, development, review,
of products that span the development cycle, with the Pharmacy Fellows who will help us achieve these MICHELLE TAYLOR, MS
approval, and updating of various documents critical to
highest degree of regulatory compliance. goals! If you love learning and developing yourself GLOBAL REGULATORY AFFAIRS PRECEPTOR
the success of Regulatory initiatives
through teamwork, if you are passionate about life Michelle Taylor is a Senior Manager in the Global
The Alexion RA fellowship is designed to provide
• SUPPORT the Regulatory leads with their contributions Regulatory Affairs, Global Labeling Operations
the fellow with hands-on exposure to a multitude of sciences and the impact R&D can bring to patients group at Alexion. She supports the lifecycle
to Regulatory projects and provide helpful insight
functions or specialties within RA and across products in suffering from rare diseases, this fellowship program management and CCDS compliance activities.
the Complement, Metabolics, Bone & Cardiomyopathy, and guidance She has 6 years of regulatory experience and
is a unique opportunity for you!
and New Modalities & Rare Cancers therapeutic areas. has 6 years in Clinical Research experience. Prior
• OBSERVE how to develop Regulatory strategy and work
to joining Alexion, Michelle worked at Shire and
The fellow will have the opportunity to build a broad, successfully with cross-functional teams and US and Brigham and Women’s Hospital on the TIMI Study Group. Michelle
robust foundation as a regulatory professional while global health authorities received her Bachelor’s Degree in Marketing from UMASS Boston
directly contributing to the development of Alexion’s SARAH RHEE, MS
and her Master’s in Clinical Research at Emmanuel College.
products and the patients they serve. Throughout • GAIN a solid understanding of the current Regulatory VICE PRESIDENT, HEAD OF ALEXION REGULATORY AFFAIRS
MORGAN LOH, PharmD
the program, the fellow will have the ability to tailor landscape, including relevant guidances, enforcement SECOND-YEAR GLOBAL REGULATORY AFFAIRS FELLOW
the program to their unique interests and overall actions, and laws, rules, and/or regulations The rotational aspect of this program is
professional development needs. especially unique – it allows its fellows to make
FOCUSED OBJECTIVES meaningful connections and contributions in
The fellow will be assigned to the project teams and will a variety of key regulatory sub-teams. I believe
work with designated RA preceptors throughout core YEAR 2 these multifaceted experiences cultivate
rotations in various sub-functions within regulatory. • REPRESENT Regulatory as an integral member at your regulatory knowledge, paving the way
to becoming a well-rounded regulatory
cross-functional meetings by providing regulatory
professional. Over the past year at Alexion, I have been fortunate
insight, owning action items, and contributing to work with talented and driven individuals who are invested
feedback and guidance on various documents in making meaningful impacts for people living with rare
and projects diseases everyday.”
Regulatory affairs is a key strategic partner AMBER CONKLIN, PharmD
• LEAD cross-functional teams through
to health authorities and various functional FIRST-YEAR GLOBAL REGULATORY AFFAIRS FELLOW
appropriate processes to comply with Regulatory
The GRA Fellowship at Alexion offers a
teams within the company. We work driven commitments comprehensive experience across different
across the drug development spectrum functional areas within Regulatory Affairs,
• SUPPORT (and potentially drive) the planning, complete with mentorship and high-quality
from research to post-marketing setting, preparation, and submission of regulatory initiatives training to strengthen regulatory skills. Alexion’s
ensuring that what we do every day brings • SERVE as the primary coordinator and Regulatory
company culture fosters collaborative teams,
enhancing our collective ability to make a
life-changing therapies to patients.” representative for US and global health significant impact in rare disease treatment. I knew that Alexion’s
authority interactions fellowship program would support my professional development
SARAH RHEE and give me the opportunity to engage with global teams focused
on delivering new medicines to patients safely and effectively.”
GLOBAL VALUE, ACCESS & PRICING We are thrilled that the Global Value, Access
& Pricing (GVAP) team will be continuing this
GVAP & HEOR TEAM
SIMU THOMAS, M Pharm, MS, PhD
VP, GLOBAL HEAD, HEOR, MEDICAL COMMUNICATION, AND TRAINING
fellowship program in collaboration with MCPHS.
Simu is the VP and Global Head of HEOR at
We are committed to mentoring new talent within
Alexion Pharmaceuticals. He has authored
2-YEAR PROGRAM our organization and this accelerated development
program will offer a hands-on opportunity to
more than 35 manuscripts and 75 congress
presentations and co-authored book
gain a skillset needed to become a future market chapters in the field of Health Economics.
GLOBAL VALUE, ACCESS & PRICING AND HEOR ENRICHMENT OPPORTUNITIES Simu holds a PhD in Pharmaceutical
access leader.
Economics from the University of Maryland
• Input into •G
 lobal Value • Strategic • Evidence • Economic model
Dossier & Life Cycle Generation (CEA & BIM) and MS in Pharmacy Administration from the University of
protocol
development Value Story Management Plan development PIERRICK ROLLET Toledo and Pharmacy degrees. Simu also serves as Adjunct
VICE PRESIDENT OF GLOBAL VALUE, ACCESS & PRICING EXECUTIVE Assistant Professor at University of Maryland and Rutgers
SPONSOR, ALEXION, ASTRAZENECA RARE DISEASE University of New Jersey.

JENNIFER POCOSKI, PharmD

HEAD OF GLOBAL BONE, RARE ONCOLOGY, & METABOLICS ACCESS AND PRICING

Jennifer is currently the Global Value, Access

& Pricing Head for the metabolic portfolio.
Jennifer has held several positions within the
access and health economics over the last 15
MCPHS, in collaboration with FOCUSED OBJECTIVES
years. She completed her two-year fellowship
VALUE, ACCESS & PRICING
Alexion, AstraZeneca Rare Disease at Bayer Pharmaceuticals in Medical Affairs
and Health Economics. She received her
• SUPPORT development of differentiated target product
is offering fellowship experience profile that fulfills cross stakeholder needs aligned to
PharmD from Northeastern University.

within Global Value, Access & robust value proposition KRYSTAL HUEY, PharmD, MS
GLOBAL VALUE, ACCESS & PRICING PRECEPTOR
Pricing (GVAP) with an enriched • DEVELOP global pricing and reimbursement (P&R)
Krystal is currently the Global Value, Access
strategies and framework in close collaboration with
Health Economics & Outcomes & Pricing lead for the metabolics programs.
launch and program teams She completed her two-year fellowship
Research (HEOR) experience. at Celgene/BMS in HEOR and GVAP. She
• CREATE and roll out value and access communication received her PharmD from Northeastern
tools and materials to support local P&R submissions Join a highly driven team. We are University and her MS in Health Outcomes,
Alexion, AstraZeneca’s Rare Disease GVAP team is and negotiations Policy and Economics from Rutgers University.
seeking a fellow to be part of a dynamic and growing committed to providing sustainable
• CULTIVATE understanding of global health care, HTA access to breakthrough innovative CRAIG WAKEFORD, BA, MA
team working in the metabolic portfolio. This is a
GLOBAL HEALTH ECONOMICS OUTCOMES RESEARCH, META+ SENIOR DIRECTOR
systems, and latest developing trends especially within
strategic role leveraging your understanding and rare diseases therapies. Our work Craig is currently the Senior Director of HEOR
rare disease
application of global healthcare, Health Technology transforms the lives of patients and at Alexion. He holds a B.A. in Economics from
Assessment (HTA) system knowledge, competitive the University of Toronto and a Masters in
their families impacted by rare, Economics from the University of Ottawa. He
insights, and clinical background to shape market FOCUSED OBJECTIVES
debilitating diseases.” has held multiple positions within HEOR and
access, pricing and reimbursement success for critical HEALTH ECONOMICS Access in the past 10 years across multiple
product launches and indications. & OUTCOMES RESEARCH PIERRICK ROLLET therapeutic areas.

This fellowship provides a unique opportunity to • COMPREHENSIVE understanding of what evidence

develop an expertise in the cross-section of GVAP & payers value across market/payer archetypes
CURRENT FELLOWS
HEOR. Global market access and health economics are • FUNDAMENTALS of economic modeling bridging
complementary functions with HTA/payers as the core to appreciation of level of evidence needed from SAIRA JATOI, PharmD COURTNEY SMITH, PharmD
stakeholder and this fellowship is designed to combine payer perspective SECOND-YEAR GVAP FELLOW FIRST-YEAR GVAP FELLOW

the strategic components of HEOR and apply them to As the inaugural GVAP fellow at The Global Value, Access, and Pricing
• INFLUENCING trial design, outcomes, and endpoint
real-world global market access problems. As a fellow, Alexion, I am grateful to be part of a fellowship at Alexion is unique in that the
strategy to support payer needs team that is enthusiastic about providing program offers exposure to complementary
you will learn to lead the development and execution of
me learning opportunities to develop fields, equipping the fellow with a
value, access, and price strategies for launch assets to • EXPOSURE to different methodologies to quantify
professionally in the Market Access space. comprehensive experience in optimal
support patient access to our medicines. As key parts and fill evidence gaps including burden of disease & The HEOR enrichment aspect of the market access strategy. I am looking forward
of the development team, we help shape the clinical unmet need program gives me the chance to work to learning from a highly experienced
cross-functionally and broaden my knowledge base. I am team, gaining tangible experience tackling complex
development program, develop value propositions that
honored to be part of a team dedicated to aiding patients challenges, and collaborating cross-functionally to ensure
help inform evidence generation activities, and establish with rare diseases.” sustainable patient access to rare disease medications.”
pricing recommendations for products in our portfolio.
US MEDICAL AFFAIRS (USMA) Dear Prospective Fellow,
We are excited to recruit and mentor new talent
US MEDICAL AFFAIRS (USMA) TEAM

MICHELLE CIAMBELLA, PharmD, RPh

US MEDICAL COMMUNICATIONS LEAD - NF1
within the US Medical Affairs team. This fellowship USMA FELLOWSHIP PROGRAM LEAD

represents our commitment to advancing medical

2-YEAR PROGRAM
Michelle graduated in 2020 from the
research and fostering the next generation of leaders University of Arizona and came to Alexion
in the field. By providing unparalleled resources and via a two-year fellowship in the GMC/GMA
program. She has found a home in US Medical
US MEDICAL AFFAIRS mentorship, we empower fellows to drive innovation
Affairs as the Medical Communications Lead
US MEDICAL US MEDICAL US MEDICAL ELECTIVE and make meaningful contributions to patient care.
for NF1. She combines a passion for teaching
EXCELLENCE DIRECTOR SCIENCE LIAISON 6 MONTHS We are looking for passionate individuals to join our and science to create best-in-class scientific educational content
6 MONTHS 6 MONTHS 6 MONTHS
team who embody the innovative spirit to break for HCPs. She is committed to the success of all fellows and can
barriers for our patients living with rare diseases. be found hosting learning opportunities.

PENNIE MOORE, PharmD, RPh

NAEEM KHAN SENIOR MEDICAL SCIENCE LIAISON – HEMATOLOGY/ NEPHROLOGY

USMA is a rotational program with 6-month rotations in US Medical VICE PRESIDENT - US MEDICAL AFFAIRS Pennie has 22 years of practice in the
health care setting as a Critical Care Clinical
Excellence, US Medical Director, and US Medical Science Liaison positions. Pharmacist and Director of Pharmacy and
The schedule for core rotations will be individualized, to align the fellow 6+ years in the pharmaceutical industry
working in medical affairs. Pennie has served
with major developments within Alexion. The program also allows for a final as a preceptor for pharmacy students and
6-month elective rotation in any area the fellow desires. residents as well as a mentor for medical residents. She has
a passion for the advancement of patient-care services and
continually improving the quality of experiential teaching
CORE ROTATION DESCRIPTIONS within the profession of pharmacy and now within the
pharmaceutical industry. She is currently a Senior MSL for
US MEDICAL US MEDICAL US MEDICAL Hematology and Nephrology and has won Alexion’s Excellence
EXCELLENCE DIRECTOR SCIENCE LIAISON Award five times while at Alexion.
Under the guidance of the Medical • Develop leadership skills and • Participate in Medical Science
Communications Leads CHLOE SADER, PharmD, RPh
fundamental knowledge in the Liaison (MSL) onboarding SENIOR MEDICAL DIRECTOR, USMA NEUROLOGY (GMG)
• Develop and update scientific area of strategic planning and certification Chloe has 16+ years of experience in the
field materials and develop an pharma/biopharma industry. Having started
• Support Medical Directors on • Provide medical support at
understanding of the medical as an intern during pharmacy school, she
tactical implementation of key medical congresses via
review process By providing unparalleled resources subsequently charted the course through
program initiatives abstract coverage, booth
• Participate in the planning and staffing and Key Opinion and mentorship, we empower Global & US Medical Affairs to her current
• Participate in cross-functional role as Senior Medical Director. In this role,
execution of USMA activities at Leader (KOL) engagement fellows to drive innovation and
projects to create internal and she is responsible for leading the strategic development and
national medical congresses make meaningful contributions to
external deliverables • Actively participate with MSLs execution of the myasthenia gravis rare disease program in the
• Identify, develop, and execute
• Contribute to strategic
in their field engagements patient care.” US, working closely with cross-functional teams, global medical,
trainings to increase scientific and neurology field medical. Chloe enjoys serving as a mentor
activities including advisory • Observe and learn from
knowledge and skill development NAEEM KHAN and helping individuals lean into their full potential.
boards, evidence generation, USMA leadership
• Work on special projects publication planning and
as needed, which further competitive differentiation
strategic imperatives
CURRENT FELLOWS

RADA ZUNICH, PharmD, RPh SAWYER PATRICK, PharmD, RPh

SECOND-YEAR US MEDICAL AFFAIRS FELLOW FIRST-YEAR US MEDICAL AFFAIRS FELLOW

ELECTIVE ROTATION DESCRIPTION The rotational nature of this fellowship Upon meeting the team at Alexion, I
The fellow will have the opportunity to extend one or more of the core rotations, or select an elective, 6-month has provided many valuable experiences that knew this fellowship was the perfect fit for me.
have contributed to my development as a Combined with ultra-rare disease exposure
rotation either within USMA or another functional area. Rotational areas may include but are not limited to:
young professional in the pharmaceutical and expert mentorship, I will be exposed to
• US Regulatory Advertising • Global Patient Safety • Scientific Communications industry. I have had the opportunity to multiple areas of Medical Affairs in a field
develop scientific field materials, assist that requires constant innovation. Since my
and Compliance (Pharmacovigilance) • Health Economics and with strategic planning, and engage start at Alexion, I have been supported by
• Quality Affairs • Commercial Outcomes Research with key opinion leaders in a variety of settings, including my preceptors and encouraged to create goals for myself to
• Global Medical Affairs • US Medical Affairs Pipeline • Field Systems and Analytics advisory boards and congresses. I am beyond grateful to work complete over the duration of my fellowship. Looking forward,
alongside incredible people who are dedicated to putting our I am eager to collaborate on multiple cross-functional projects
• Clinical Development • US Medical Review • Medical Information and champion new solutions for our patients.”
patients first.”
 PHARMACEUTICAL DEVELOPMENT AND
PHARMACEUTICAL DEVELOPMENT At Alexion, we are committed to building a
world-class organization and our people are our
CLINICAL SUPPLY FELLOWSHIP TEAM

AND CLINICAL SUPPLY greatest asset for creating those opportunities of

growth, learning, and collaboration. Our partnership
RAYHAN SHAIKH, PharmD, BCSCP, RPh, MBA
PHARMACEUTICAL DEVELOPMENT AND CLINICAL SUPPLY PROGRAM LEAD

BASED IN NEW HAVEN, CT Rayhan is an Associate Director in Clinical

with MCPHS and its fellowship program is an Supply Management and the PDCS
exciting opportunity because it accelerates that fellowship lead. Rayhan has 12+ years of

2-YEAR PROGRAM impact and allows fellows to learn firsthand through

supporting Alexion’s clinical studies.
clinical hospital experience as well as 8 years
of global product development and clinical
supply experience. He received his PharmD
The mentorship and support that fellows will receive from the University of Connecticut and his
ONBOARDING + DEVELOPMENT INTERACTIVE INJECTABLES ELECTIVE(S)
MBA from the University of Rhode Island.
CLINICAL SUPPLY SUPPLY QUALITY RESPONSE DRUG 12 MONTHS through this partnership is unparalleled and will
MANAGEMENT 3 MONTHS TECHNOLOGY PRODUCT
showcase our great talent and commitment to CHRISTIN LABELLE, BA, MPH
6 MONTHS 2 MONTHS DEVELOPMENT
CLINICAL SUPPLY QUALITY LEAD
1 MONTH individual learning and growth.
Christin is a Senior Specialist in Development
The Pharmaceutical Development and Clinical Supply Quality and has 20 years of experience
Supply team is committed to supporting Alexion’s in the Pharma Industry. Her experience
includes quality control/assurance,
The Pharmaceutical Development & Clinical Supply (PDCS) fellowship is clinical studies with the highest level of service and Pharmacovigilance, clinical research,
treatment for our patients. Clinical Supply for rare
designed to provide fellows the opportunity to collaborate cross-functionally, and training. She received her MPH in
disease indications present nuanced challenges Epidemiology from the Boston University
build leadership skills through applied, hands-on experience, and develop that pave the way for innovative thinking. By joining
School of Public Health and her BA in Neuroscience from
Wheaton College.
strong relationships with biopharmaceutical industry leaders. Through Alexion, you will become part of a larger team and
IMRAN SHAKUR, BS
their participation, fellows will build their subject matter expertise and be community, one steeped in patient-centered care
IRT AND TECHNOLOGY PRECEPTOR
and cutting-edge science.
committed partners in advancing Alexion’s mission and values. Imran is the Director of PDCS Clinical Supply
IRT and Technology Lead at Alexion. Imran
has over 20 years of experience in clinical
CORE ROTATION DESCRIPTIONS MARK SWIFT, BS, JD research focusing on technology in clinical
CLINICAL SUPPLY DEVELOPMENT SUPPLY INTERACTIVE RESPONSE EXECUTIVE DIRECTOR & HEAD, CLINICAL SUPPLY AND EXTERNAL supply chain systems and IRT/RTSM. Imran
MANAGEMENT QUALITY TECHNOLOGY (IRT) MANUFACTURING ALEXION, ASTRAZENECA RARE DISEASE began his career working on the vendor
• Oversee contract manufacturing • Ensure quality oversight linked • Support cross functional, global side of the IRT/RTSM business as Project
packaging, labeling, and to risk management, change study teams in the end-to-end Manager and eventually moved to the Sponsor side working
at companies that include Takeda, Boehringer Ingelheim,
international shipping/distribution control implementation, deviation/ set-up, delivery, maintenance, and
and Biogen.
operations for Investigational investigation review, Corrective archival of IRT systems as the IRT
Medicinal Product (IMP) ensuring and Preventive Actions (CAPAs), subject matter expert KATIRIA FLORES, BS, MS, PhD
on time delivery to support clinical periodic review of trial master • Coordinating with and managing
INJECTABLES DRUG PRODUCT DEVELOPMENT PRECEPTOR

trials file (TMF), damaged kit report Katiria is a Senior Scientist in the Injectables
the IRT vendor on delivering
disposition, site to site transfer Drug Product Development. Katiria has
• Work with Clinical Operations, IRT systems in adherence to
of investigational product (IP) 7 years of experience leading the clinical
Quality Assurance (QA) and study timelines, IRT standards, in-use compatibility studies. Her work has
Regulatory to develop kits and approval, Quality Check (QC) and in accordance to regulatory supported intravenous and subcutaneous
label text for multiple countries/ review and approval of clinical requirements and guidelines drug product administration for 12 Alexion
regions and provide support for study medication list generation/
• Ensuring user acceptance testing products in different cycles/phases. Katiria
Investigational New Drug (IND) site labeling operations, received her BS in Industrial Microbiology from the University
oversight of temperature (UAT) is performed as needed
filings as required. of Puerto Rico and her MS and PhD in Physiology and
excursion assessments. including authoring UAT test
Neurobiology from the University of Connecticut.
• Manage development of plans, coordinating with the IRT
• Support review, approval, and
pharmacy manuals with vendor on delivery and support,
maintenance of pharmacy AISHA KHOKHAR, PharmD, MHS
appropriate internal subject and supporting the study team FIRST-YEAR PHARMACEUTICAL DEVELOPMENT AND CLINICAL SUPPLY FELLOW
matter experts. manuals across all applicable on UAT
studies. I am thrilled to join Alexion as the
• Prepare supply and cost forecasts
• Subject-Matter Expert (SME)/point inaugural PDCS fellow. With a PharmD and
as required. Identify cost reduction MHS in Clinical Research, my background
opportunities and develop and of contact for clinical sites and By joining Alexion, you will become
spans retail and institutional pharmacy, as
Health Authority inspections.​​
manage clinical supply budget part of a larger team and community, well as some time at the FDA, but my true
• Quality contact approval of process passion lies in pharmaceutical research.
one steeped in patient-centered care
improvements/periodic review for From day one, the supportive and inclusive
PDCS related procedures. and cutting-edge science.” team at Alexion has empowered me to feel confident in my
role. I am excited to contribute to Alexion’s diverse pipeline and
MARK SWIFT make a meaningful impact in treatments for rare diseases.”
US REVIEW AND STRATEGY The USMA, US Medical Review
and US Advertising and
US REVIEW AND STRATEGY
FELLOWSHIP TEAM
MATTHEW MAULIS, PharmD
Promotional Compliance teams US REVIEW AND STRATEGY PROGRAM LEAD

Matthew is an Associate Director and

are thrilled to announce a new currently supports US Medical Review within

fellowship program at Alexion, the hematology & nephrology therapeutic

2-YEAR PROGRAM in partnership with MCPHS.

area, serving as the lead hematology medical
reviewer. He received his PharmD from
Lipscomb University in 2018 and completed
a post-doctoral fellowship in Medical
US AD PROMO US MEDICAL DIRECTOR US MEDICAL REVIEW ELECTIVE This initiative reflects our dedication to nurturing
6 MONTHS 6 MONTHS 6 MONTHS 6 MONTHS Information & Medical Affairs with Sunovion Pharmaceuticals
emerging talent within our organization and and MCPHS University. After completing his fellowship, he
engaging enthusiastic individuals to lead the remained at Sunovion, and served as both a preceptor and
director of their fellowship program. Matthew enjoys mentoring
expansion of our team. This innovative program is
fellows and assisting them in discovering their path within the
designed to offer a comprehensive and immersive industry and ensuring they have all the tools necessary for a
experience in navigating the complexities of successful career within the industry.
US Review and Strategy is a rotational program with 6-month rotations in US medical and regulatory landscapes.
MICHELLE BELLIVEAU, MLS, MSRA
Advertising and Promotional Compliance (Ad Promo), US Medical Director, Fellows will gain hands-on experience, work closely REGULATORY ADVERTISING AND PROMOTIONAL COMPLIANCE

and US Medical Review. The schedule for core rotations will be individualized, with industry experts, and develop critical skills Michelle Belliveau works within US Medical
needed to excel in these pivotal areas. Affairs, providing Regulatory Advertising
to align the fellow with major developments within Alexion. The program also and Promotional Compliance support for
We look forward to supporting the professional
allows for a final 6-month elective rotation in any area the fellow desires. marketed and investigational products
growth of the next generation of leaders in within the Rare Disease Business Unit,
primarily focusing on therapeutic areas
medical and regulatory review through this
CORE ROTATION DESCRIPTIONS within metabolics. Prior to working at
exciting opportunity. Alexion, AstraZeneca Rare Disease, other industry experience
US AD PROMO US MEDICAL DIRECTOR US MEDICAL REVIEW included Takeda Pharmaceuticals, supporting the Oncology
Business Unit in various roles within Regulatory Affairs,
• Provide strategic, high-quality, • Develop leadership skills and • Develop mastery of clinical
Marketing, and Quality Assurance. Michelle attended
timely and decisive advice on fundamental knowledge in the data and regulations regarding Massachusetts College of Pharmacy and Health Sciences
advertising and promotional area of strategic planning promotion and scientific exchange obtaining a Masters in Regulatory Affairs and Health Policy,
materials, communications, and • Support Medical Directors on • Demonstrate subject matter as well as Simmons College, obtaining a Masters in Library
company activities in accordance tactical implementation of key expertise in both disease state and and Information Science with a specialization in Archives
with FDA regulations, company program initiatives product(s) by actively participating Management, working within multiple libraries within
policies, and business goals in promotional review and medical Boston, MA.
• Participate in cross-functional
• Support the dissemination of review committee meetings and
projects to create internal and
new or updated FDA policies, defending any comments ALYSSA BOWLING, PharmD, RPh
external deliverables ASSOCIATE MEDICAL DIRECTOR, NF-1
enforcement actions or guidance • Support, collaborate, and provide
documents • Contribute to strategic activities Alyssa has 8+ years of experience in the
including advisory boards, guidance to/with cross-functional pharmaceutical industry. After graduating
• Support regulatory leads on partners from the University of Michigan she
evidence generation, publication
projects and initiatives planning and competitive • Support, attend, and provide completed a fellowship in Medical Affairs
• Assist and support 2253 guidance for any promotional at Sunovion Pharmaceuticals through
differentiation
submissions to the Office of video shoots MCPHS. She spent a few years in Scientific
Communications before moving into Medical
Prescription Drug Promotion
Strategy-focused roles, and now serves as an Associate Medical
(OPDP) Director for NF-1. Alyssa enjoys helping fellows take advantage
of all the opportunities the program provides and doing her
part to set fellows up for a successful career in the industry.
ELECTIVE ROTATION DESCRIPTION
The fellow will have the opportunity to extend one or more of the core rotations, or select an elective, 6-month
rotation either within USMA or another functional area. Rotational areas may include but are not limited to:

• US Medical Science Liaison • Global Patient Safety • Scientific Communications

• Medical Information (Pharmacovigilance) • Health Economics and

• Commercial Outcomes Research
• Global Medical Affairs
• US Medical Affairs Pipeline • Field Systems and Analytics
• Clinical Development
REFLECTIONS FROM
PAST FELLOWS
GABRIELA MARCHEVA, PharmD 2017–2019 DIAN LIN, PharmD 2019–2021
GLOBAL LIFE CYCLE MANAGEMENT DIRECTOR, IMMUNE THROMBOTIC SENIOR MANAGER, PAYER AND CHANNEL MARKETING AT BIOGEN
THROMBOCYTOPENIA PURPURA AT SANOFI

The Alexion fellowship program

Through the two-year Alexion fellowship has given me the unique opportunity MICHELLE CIAMBELLA, PharmD, RPh 2020–2022 PAUL PARK, PharmD 2022-2024
program, I was able to dive deep into a to gain extensive experience in Medical MEDICAL COMMUNICATIONS LEAD FOR META+ NF1-PN AT ALEXION SENIOR MANAGER, NORTH AMERICA MEDICAL AT RHYTHM PHARMACEUTICALS
variety of meaningful projects with ambitious Communications, Medical Affairs, and Payer
cross- functional teams, and the skills I The fellowship provided me with many The fellowship program gave me a
Marketing. The rotational aspect of the
started developing led me to where I am meaningful experiences that prepared me holistic view of medical affairs/medical
fellowship has allowed me to build upon my
today in my current role. Active involvement for my full-time position. I’m grateful for the communications and each rotation offered
therapeutic area knowledge and core competencies to engage
as a fellow is the key to success, and I strongly encourage opportunity and all the friendships I made as me such unique opportunities. I was very
in cross- function medical and commercial activities that best
taking every possible opportunity to lead projects and engage well as the mentoring I received at Alexion.” blessed to work with amazing and passionate
serve patients with rare disease.”
with team members.” mentors and coworkers who made the
fellowship such an amazing experience!”
ALEXANDRA MARESH, PharmD, RPh 2020–2022
MICHAEL MCDERMOTT, PharmD, RPh 2021–2023
ADAM QUICQUARO, PharmD 2018–2020 ASSOCIATE DIRECTOR, US MEDICAL REVIEW AT ALEXION
SENIOR MANAGER, SAFETY SCIENTIST AT ALEXION
ASSOCIATE DIRECTOR, CLINICAL DEVELOPMENT SCIENCES AT ALEXION BRIAN ARANA-MADRIZ, PharmD 2022-2024
Working with such passionate, SENIOR MANAGER, REGULATORY AFFAIRS AT ASTRIA THERAPEUTICS
The Patient Safety fellowship program
The Alexion Fellowship program motivated individuals throughout my
was an invaluable experience that propelled The Alexion fellowship program
exposed me to a unique variety of cross- fellowship solidified my desire to stay on as
my career in the biopharmaceutical industry. provided me with the opportunity to learn
functional experiences that allowed me a full-time member of the team. I feel very
Through thoughtful mentorship and hands- from industry professionals, enabling me
to develop a broad skillset which truly fortunate to have gained experience learning
on training, I gained the knowledge and skills to sharpen and develop skills that would
prepared me for my current role today. It also from so many skilled mentors who always
needed to navigate the complex landscape otherwise have been inaccessible to me.
provided a stimulating work environment provided me with support and encouragement.”
of the pharmacovigilance, ultimately allowing me to have an Engaging with established professionals
that fostered my development as a professional and offered
meaningful impact on patient safety.” allowed me to gain valuable perspectives and find mentors
me the opportunity to serve rare disease patients with unmet CALANTHA YAN, PharmD, RPh 2020–2022
who believed in me, equipping me with the tools to achieve
medical needs.” SENIOR SAFETY SCIENTIST AT SEAGEN

ALEXANDRA BURGER, PharmD 2021–2023 my current position. Most importantly, I built a network of
The fellowship at Alexion, AstraZeneca SENIOR MANAGER, PAYER AND CHANNEL MARKETING AT ALEXION dependable individuals whom I can always rely on.”
MATTHEW LUEN, PharmD 2018–2020 Rare Disease was a great way to jumpstart
HCP MARKETING AT AMGEN
my career in the pharmaceutical industry! The Alexion, AstraZeneca Rare Disease
MAYA OSMAN, PharmD 2022-2024
The vast majority of my training was focused fellowship program equipped me with MEDICAL SCIENCE LIAISON AT AMGEN
The Alexion fellowship program
on drug safety, but I also gained cross- valuable experiences that readied me for my
was a great opportunity to learn from Completing my fellowship at Alexion
functional exposure during my time in the full-time role. I feel incredibly lucky to have
and contribute to many different teams. was incredibly fulfilling as it gave me the
program. These experiences strengthened my understanding had the opportunity to learn from numerous
Throughout my fellowship experience, I was opportunity to work alongside experts from
of the role of the safety scientist as well as broadened my mentors who consistently offered me
able to work in both medical and commercial diverse backgrounds and enriched my
perspective of how the functional areas work together. The unwavering support and motivation.”
facing functions to solve complex challenges, understanding of global medical affairs. I am
knowledge that I acquired shaped me into a valuable candidate
and ultimately provide the best solutions for patients.” extremely grateful for this experience and the
upon the conclusion of my training.” JANKI PATEL, PharmD, RPh 2022-2024
valuable connections I got to build along the way!”
SENIOR MANAGER, SAFETY SCIENTIST AT ALEXION
KATIE SWANNER, PharmD 2019–2021 CHRISTINE BORUNDA, PharmD, RPh 2020–2022
DIRECTOR, MEDICAL AFFAIRS AT INOZYME PHARMA
MEDICAL SCIENCE LIAISON IN NEUROLOGY AT ALEXION The Global Patient Safety fellowship Tim O’Neill, PharmD, RPh 2022-2024
gave me a strong foundation of
The Alexion GMC/GMA fellowship My program allowed me to focus on
The opportunity to train hands-on in experiences needed to excel in a career in
program allowed me to explore multiple the specific functions of each rotation
multiple functional areas allowed me to pharmacovigilance. The Alexion fellowship
functions while equipping me with the individually while giving me the flexibility
understand each team’s role in the bigger program is filled with passionate and
valuable skill sets that I use today, including to get invested in larger projects and even
scheme of things. This ultimately granted knowledgeable mentors that are one of a
cross-functional collaboration, project lead them. You learn everything you need
freedom to explore different types of work kind and have made my first experience in the pharmaceutical
management, and communication of to be successful and at a high level of
and align my interest to my current role.” industry a memorable one.”
scientific literature.” each function.”
 MCPHS MCPHS TEAM
AMEE MISTRY, PharmD, RPh SHEILA SEED, PharmD, MPH, CTH®, AFTM RCPS(Glasg), RPh
DIRECTOR OF THE POSTDOCTORAL BIOPHARMACEUTICAL INDUSTRY MCPHS FACULTY PRECEPTOR
FELLOWSHIP PROGRAM AND MCPHS FACULTY PRECEPTOR
Sheila Seed is Professor and Chair for the
Dr. Amee Mistry is a Professor of Department of Pharmacy Practice at the
Massachusetts College of Pharmacy and
Pharmacy Practice and has been with
Health Sciences (MCPHS) School of Pharmacy
MCPHS since 2006. Dr. Mistry earned
Worcester/Manchester campuses. During
her PharmD at the Albany College of
the pandemic, she served as the University’s
Pharmacy and completed a PGY1 COVID-19 Coordinator for all three campuses.
Community Practice Residency with She received her B.S in Pharmacy from the Massachusetts College
Walgreens and MCPHS. In 2015, Dr. Mistry took over as of Pharmacy and Health Sciences, Boston, Masters of Public Health
Director of the MCPHS Biopharmaceutical Industry from the University of Massachusetts, Amherst and Doctor of
Fellowship program. She works directly with leaders Pharmacy (Pharm.D.) from Idaho State University. She has been a
in the area to continue to foster growth and development faculty member at MCPHS since 2001. Prior to her appointment,
of the post graduate program, and to assist the fellows in she worked in the community setting and as a pharmacy officer
attaining positions within the pharmaceutical industry. She in the U.S. Air Force. Her areas of interests include public health,
immunizations and travel medicine. She has a Certificate of Travel
also continues to teach and conduct scholarly work at MCPHS,
Health™ (CTH)®, and is an Associate Faculty Member of Travel
trains pharmacists and student pharmacists nationally on
Medicine at the Royal College of Physicians and Surgeons (Glasgow).
immunizations, and is actively involved in her state and
She has served as the Secretary of Knowledge Management and
national pharmacy organizations. the Chair of the AACP Public Health SIG and a past Coordinator of
the APhA Immunization SIG. She continues to work with the SIG on
MCPHS provides an academic environment to guide and support TRISHA LAPOINTE, PharmD, BCPS, FASHP, RPh updating the APhA Travel Health Quick Guide annually.
MCPHS FACULTY PRECEPTOR
fellows toward a successful career in the biopharmaceutical YULIA MURRAY, PharmD, RPh
Dr. LaPointe is a Professor of Pharmacy MCPHS FACULTY PRECEPTOR
industry. As a private institution with a history of specializing in Practice at MCPHS. She earned her Dr. Yulia Murray received a Doctor of Pharmacy
health sciences, MCPHS offers programs that embody scholarship, doctorate in pharmacy from Northeastern degree from MCPHS University School of
Pharmacy Worcester in 2007. Following
University in 2001 and completed her
professional service, and community outreach. PGY-1 at Massachusetts General Hospital graduation, Yulia completed a PGY-1 residency
in Boston Massachusetts. Dr. LaPointe’s at Beth Israel Deaconess Medical Center
current practice site at Lowell General Hospital where she sees (BIDMC). After completing residency year, Yulia
Through the affiliation with MCPHS, fellows will have the took a position as a Clinical Medicine Pharmacist
patients in the inpatient care setting and mentors student
opportunity to gain teaching and research experience at Boston Medical Center and worked in that role for four years,
pharmacists on inpatients general medicine rotations. Dr.
in an academic setting. MCPHS faculty and company while also staying on as a per-diem clinical pharmacist at BIDMC.
The Alexion fellowship provides a LaPointe works with students, residents, and fellows to carry
In 2012, Yulia decided to pursue a career in academia and was
program leaders mentor fellows according to their out scholarly pursuits.
unique opportunity to gain practical and offered a position as an Assistant Professor of Pharmacy Practice
scholarly and professional interests throughout the at MCPHS University School of Pharmacy Boston. Currently, Yulia
valuable hands on experience that will
two-year program. EWAN MCNICOL, PharmD, RPh serves as an Associate Professor of Pharmacy Practice with her
allow for a successful and fruitful career MCPHS FACULTY PRECEPTOR clinical site at Newton-Wellesley Hospital.
in the biopharmaceutical industry.”
AS AN ADJUNCT INSTRUCTOR AT MCPHS, FELLOWS Dr. McNicol is an Associate Professor of PHUNG ON, PharmD, RPh
Pharmacy Practice at MCPHS where he MCPHS FACULTY PRECEPTOR
WILL HAVE THE OPPORTUNITY TO: MATTHEW LUEN
maintains a practice site in ambulatory Dr. Phung On is an Associate Professor of
Past Fellow, Global Medical Communications–Global
• DEVELOP, coordinate, and teach courses Medical Affairs
pain management at Atrius Health Pharmacy Practice at MCPHS. She is the
in Boston. He received his Doctor of Academic Coordinator on the Boston Campus
• CO-PRECEPT pharmacy students on advanced for the Biopharmaceutical Industry Fellowship
Pharmacy degree from MCPHS in Boston
experiential rotations in 2016. In addition, he has a Master’s degree in Pain Research, program and the Coordinator of Diversity, Equity,
and Inclusion for the School of Pharmacy –
• CREATE and publish scholarly research and/or Education and Policy from Tufts University from 2001. He
Boston. She earned her PharmD at MCPHS in
conducts evidence-based reviews of analgesic interventions
review articles Boston in 2013 and completed a PGY1 Pharmacy Practice Residency
and outcomes for pain and related conditions, and has
with a focus on ambulatory care, managed care, and transitions
• PRESENT research at scientific and clinical meetings collaborated with current and former pharmacy fellows as a of care through the University of North Carolina in Chapel Hill and
preceptor in this research. AccessCare, a network of Community Care of North Carolina. Dr.
• PARTICIPATE in professional development seminars
On maintains a clinical practice site in ambulatory care at Codman
with other MCPHS fellows Square Health Center in Boston where she works collaboratively
with the primary care team to manage patients’ chronic diseases.
APPLICATION
REQUIREMENTS
ELIGIBILITY APPLICATION REVIEW AND INTERVIEW TIMELINE
The MCPHS Biopharmaceutical Industry fellows will be Following a review of submitted applications, pre-screens
selected on a nationally competitive basis. Applicants and preliminary interviews will begin in October. Additional
must have a Doctor of Pharmacy degree from an ACPE interviews, including final rounds will take place in
accredited college of pharmacy at the commencement of December during ASHP. Candidates will be notified if
the program. selected for an interview. The process is rigorous and
competitive; therefore candidates should submit their
• Candidates must have strong written and verbal
applications well in advance of posted deadlines as priority
communication skills and a strong interest in pursuing a
will be given to those who apply early.
career within the biopharmaceutical industry.

• All candidates must have authorization to work in the

ASHP MIDYEAR & ONSITE INTERVIEWS
United States throughout the duration of the one or two
year fellowship. No visa sponsorship will be provided (i.e., The fellowship program will be conducting in-person
TN, H-1B, STEM OPT, etc.). interviews at the ASHP Midyear Clinical Meeting in New
Orleans, LA. Applicants are strongly encouraged to attend,
but it is not required. Candidates attending in-person
APPLICATION PROCEDURE
will not be able to interview without registering for both
The MCPHS application portal (SMApply) will open on ASHP and PPS. Please refer to the ASHP & PPS website for
Monday October 7th, 2024. Applicants must upload the registration details.
following application materials to the online portal (https://
Top candidates may be invited for interviews at the
mcphs.smapply.io) by Monday November 4, 2024:
sponsoring company’s location.
• Letter of intent

• Curriculum vitae AIFA FIRST OFFER DATE

• Unofficial college transcript The choice of a Postdoctoral Fellowship is an important

decision. MCPHS, in conjunction with the Alliance of
• Contact information for three references. References
Industry Fellowship Associates (AIFA), has aligned to extend
will receive an electronic recommendation form to
offers for Fellowships no earlier than December 16th, 2024.
complete separately.
We believe this is a positive reflection of the cultures our
Programs offer and that culture is a critical consideration
Three recommendation evaluation forms must be in choice of Fellowship. We hope that other academic and
submitted no later than November 20, 2024 via the online non-academic Fellowship Programs will NOT pressure
portal. This is NOT a letter of recommendation but an online candidates to accept offers prior to this aligned offer date.
form that the recommender will receive for completion
from SMApply.
ONBOARDING
Final candidates will be required to go through additional
screening / onboarding as required by MCPHS.

FOR MORE INFORMATION, PLEASE EMAIL:

[email protected]

BOSTON CAMPUS MANCHESTER CAMPUS WORCESTER CAMPUS

179 Longwood Avenue 1260 Elm Street 19 Foster Street
Boston, MA 02115-5896 Manchester, NH 03101 Worcester, MA 01608-1715

Alexion Pharmaceuticals, Inc.

121 Seaport Boulevard
Boston, MA 02210